JG
Jason Gerberry BofA Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
21
Avg Return
Past Year
Past Year
10%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
66.7%
Neutral
22.2%
Negative
11.1%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $275 |
16%
upside
| 2 | +3.4% |
0
%
| 25 Feb ‘26 3 months ago |
|
|
|
Underperform
Maintained
| $28 |
11%
downside
| 1 | +0.5% |
0
%
| 25 Feb ‘26 3 months ago |
|
|
|
Neutral
Maintained
| $34 |
19%
downside
| 1 | – |
–
| 20 Feb ‘26 3 months ago |
|
|
|
Neutral
Maintained
| $28 |
7%
upside
| 1 | – |
–
| 15 Dec ‘25 5 months ago |
|
|
|
Buy
Maintained
| $81 |
4%
upside
| 2 | +6.7% |
0
%
| 9 Dec ‘25 5 months ago |
|
|
|
Buy
Maintained
| $97 |
27%
upside
| 2 | +11% |
0
%
| 9 Dec ‘25 5 months ago |
|
|
|
Buy
Maintained
| $32 |
9%
downside
| 2 | +32% |
0
%
| 9 Dec ‘25 5 months ago |
|
|
|
Buy
Maintained
| $29 |
28%
upside
| 1 | +37% |
0
%
| 13 Nov ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $32 |
70%
upside
| 1 | – |
–
| 26 Aug ‘25 9 months ago |
|
|
|
Buy
Maintained
| $30 |
10%
downside
| 2 | +24% |
0
%
| 12 Aug ‘25 9 months ago |
|
|
|
Buy
Maintained
| $49 |
345%
upside
| 1 | -28% |
0
%
| 12 Aug ‘25 9 months ago |
|
|
|
Buy
Maintained
| $176 |
25%
downside
| 1 | +49% |
0
%
| 5 Aug ‘25 9 months ago |
|
|
|
Underperform
Downgraded
| $1 |
45%
downside
| 1 | -225% |
0
%
| 30 Jun ‘25 11 months ago |
|
|
|
Buy
Maintained
| $23 |
63%
downside
| 1 | +137% |
0
%
| 11 Jun ‘25 11 months ago |
|
|
|
Neutral
Maintained
| $46 |
9%
downside
| 1 | +37% |
–
| 5 Jun ‘25 11 months ago |
|